VIRI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Virios Therapeutics Insider Trading History Chart

Virios Therapeutics Share Price & Price History

^$2.32

▼ -0.1 (-4.13%)

As of 12/19/2024 01:00 AM ET

Days: 30 | 90 | 365

Missed Nvidia? Buy Elon Musk’s “Silent Partner”

From Brownstone Research | Ad

In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.

So please click here to see the details because a lot of people could get rich.

Virios Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/21/2023	William Pridgen	Director	Buy	15,335	$1.30	$19,935.50	52,045
8/17/2023	Gregory Scott Duncan	CEO	Buy	25,000	$1.25	$31,250.00	57,461
12/8/2022	Richard James Whitley	Director	Sell	1,800	$0.26	$468.00	700
5/23/2022	Angela Walsh	SVP	Buy	2,000	$4.58	$9,160.00	3,000
5/23/2022	Gregory Scott Duncan	CEO	Buy	7,500	$4.52	$33,900.00	32,461
5/17/2022	William Pridgen	Director	Buy	13,450	$4.38	$58,911.00	36,469
3/29/2022	William Pridgen	Director	Buy	600	$4.94	$2,964.00
3/23/2022	William Pridgen	Director	Buy	2,197	$5.46	$11,995.62
1/27/2022	William Pridgen	Director	Buy	4,180	$5.98	$24,996.40
1/6/2022	Richard James Whitley	Director	Buy	1,800	$5.72	$10,296.00
12/23/2021	Richard James Whitley	Director	Buy	200	$5.72	$1,144.00

I was wrong. Dead wrong.

From Porter & Company | Ad

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.

SEC Filings (Institutional Ownership Changes) for Virios Therapeutics (NASDAQ:VIRI)

9.05% of Virios Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Virios Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/8/2023	Belvedere Trading LLC	18,142	$25K	0.0%	N/A	0.099%
7/28/2023	McCollum Christoferson Group LLC	30,700	$42K	0.0%	N/A	0.168%
11/7/2022	Warberg Asset Management LLC	200,000	$74K	0.0%	N/A	2.401%
10/13/2022	PVG Asset Management Corp	80,590	$31K	0.1%	N/A	0.967%
7/12/2022	Koshinski Asset Management Inc.	40,924	$0.17M	0.0%	N/A	0.491%
7/6/2022	Wiley BROS. Aintree Capital LLC	11,000	$47K	0.0%	N/A	0.132%
5/12/2022	Cetera Advisors LLC	43,944	$0.20M	0.0%	+22.0%	0.528%
11/16/2021	Captrust Financial Advisors	40,145	$0.21M	0.0%	N/A	0.482%
11/16/2021	Cetera Advisors LLC	48,432	$0.26M	0.0%	+100.0%	0.581%
11/16/2021	Masters Capital Management LLC	650,000	$3.44M	0.1%	+8.3%	7.803%
11/9/2021	BlackRock Inc.	15,856	$84K	0.0%	+64.3%	0.190%
9/17/2021	Virtu Financial LLC	13,110	$82K	0.0%	N/A	0.157%
8/13/2021	Geode Capital Management LLC	18,499	$0.12M	0.0%	N/A	0.222%
8/13/2021	Vanguard Group Inc.	141,011	$0.89M	0.0%	N/A	1.693%
5/18/2021	Millennium Management LLC	22,858	$0.13M	0.0%	+10.4%	0.274%
5/17/2021	Masters Capital Management LLC	600,000	$3.44M	0.1%	+33.9%	7.203%
5/14/2021	PVG Asset Management Corp	55,160	$0.32M	1.0%	N/A	0.662%
5/4/2021	Envestnet Asset Management Inc.	27,844	$0.16M	0.0%	N/A	0.334%
2/24/2021	Virtu Financial LLC	35,219	$0.26M	0.0%	N/A	0.450%
2/17/2021	Jane Street Group LLC	95,230	$0.72M	0.0%	N/A	1.216%

Data available starting January 2016

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.

Today's Range

Now: $2.32

$2.32

$2.44

50 Day Range

MA: $3.31

$1.85

$4.99

52 Week Range

Now: $2.32

$0.13

$1.04

Volume

10,712 shs

Average Volume

1,049,645 shs

Market Capitalization

$44.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.58

Who are the company insiders with the largest holdings of Virios Therapeutics?: Virios Therapeutics' top insider investors include:
Gregory Scott Duncan (CEO)
William Pridgen (Director)
Learn More about top insider investors at Virios Therapeutics.